Clinical Trials Browser

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06023862 2025-06-15

DOVE

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT03367871 2024-06-18

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Phase 2 Terminated

17 enrolled 12 charts

Gynecologic

Uterine Cervical Neoplasms

NCT03476798 2024-02-15

Clovis-001

Phase 2 Completed

49 enrolled 13 charts

Gynecologic

Uterine Cervical Neoplasms, Endometrial Neoplasms

NCT05247619 2022-07-15

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

Phase 2 Unknown

49 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05444374 2022-07-05

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

Phase 2 Unknown

48 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04974944 2021-10-01

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Phase 2 Unknown

172 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT04973904 2021-07-22

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

Phase 2 Unknown

35 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT02835833 2018-07-10

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Phase 1 Completed

21 enrolled

GenitourinaryGynecologic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms

NCT00600210 2017-08-23

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Phase 2 Withdrawn

Gynecologic

Uterine Cervical Neoplasms

NCT00545792 2017-03-15

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

Phase 2 Completed

21 enrolled 9 charts

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT00548418 2014-08-01

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Phase 2 Completed

27 enrolled 14 charts

Gynecologic

Uterine Cervical Neoplasms

NCT00626561 2014-07-07

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix

Phase 2 Terminated

4 enrolled 2 charts

Gynecologic

Uterine Cervical Neoplasms, Uterine Neoplasms

Clinical Trials

ANGELICA

DOVE

Combination Pembrolizumab, Chemotherapy and Bevacizumab in Patients With Cervical Cancer

Clovis-001

A Clinical Study to Explore the Efficacy and Safety of Tislelizumab in Combination With Bevacizumab and Chemotherapy in Patients With Persistent, Recurrent, or Metastatic Cervical Cancer

A Phase II Study of Serplulimab Plus Bevacizumab in Combination With Chemotherapy in 1L Treatment of Untreated Recurrent or Metastatic Cervical Cancer

First-line Treatment With Camrelizumab + Apatinib Versus Chemotherapy + Bevacizumab in Advanced Cervical Cancer

Toripalimab Combined With Chemotherapy and Bevacizumab as First-Line Treatment in Patients With Advanced Cervical Cancer

Study of Nintedanib Plus Bevacizumab in Advanced Solid Tumors

Neoadjuvant Bevacizumab and Carboplatin Followed by Concurrent Bevacizumab, Carboplatin and Radiotherapy in the Primary Treatment of Cervix Cancer

Safety Study Of Avastin And Pelvic Radiation In Women With Recurrent Gynecological Cancers

Topotecan, Cisplatin and Bevacizumab for Recurrent/Persistent Cervical Cancer

Bevacizumab and Paclitaxel for Neuroendocrine Tumors of the Cervix